Population Pharmacokinetics and Dosage Optimization of Vancomycin in Pediatric Patients with Skin and Soft Tissue Infections, Bone, and Joint Infections.

Abstract

Vancomycin is recommended for the treatment of skin and soft tissue infections (SSTI) and bone and joint infections (BJI). However, a detailed investigation of the pharmacokinetic profile and optimal dosing regimens of vancomycin in pediatric patients with SSTI and BJI is lacking. We successfully developed a new PopPK model of vancomycin in this population by using scavenged blood samples with the typical values for clearance (CL) of 0.14 L/h/kg and volume of distribution (V) of 0.5 L/kg. Body weight was confirmed as the significant covariate on CL and V. The optimal dosing regimens of 75 mg/kg/day and 80 mg/kg/day were recommended for this specific population.

• Authors: Meng Lv, Ping Yang, Shengnan Zhang, Lingling Wang, Keming Sun, Libo Zhao
• Journal: Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 67 Issue 1 Pg. e0162422 (01 24 2023) ISSN: 1098-6596 [Electronic] United States
• PMID: 36622172 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vancomycin
• Anti-Bacterial Agents

Topics

• Humans
• Child
• Vancomycin
• Anti-Bacterial Agents (pharmacokinetics)
• Soft Tissue Infections (drug therapy)
• Models, Biological